Jump to section
To be the first global healthcare review platform trusted by people and providers everywhere.
15% employee growth in 12 months
The global patient platform Doctify was launched after its founders - two orthopedic surgeons - noticed how difficult it was to find reliable, representative, and verified healthcare reviews. The inability to easily access feedback was affecting patients as well as doctors, dentists, and hospitals. Doctify's online platform connects patients with healthcare specialists, allowing them to collect comprehensive and meaningful feedback.
A core tenet of the platform is the feedback loop that enables patients to provide meaningful reviews of their experience, letting practices improve the services they provide whilst allowing patients to make more informed decisions about where they are treated. Now operating in six markets, Doctify has provided thousands of its doctors and healthcare practitioners with video conferencing tools – allowing them to continue providing remote services where required.
In 2024, Doctify was featured in the Financial Times FT1000 as one of the fastest-growing companies in Europe. After 2023 funding from the likes of Beringea and Amadeus Capital Partners, it plans to continue expanding internationally and invest in sales and marketing.
Kirsty
Company Specialist at Welcome to the Jungle
Feb 2023
$10m
EARLY VC
Apr 2021
$7.5m
EARLY VC
This company has top investors
Dr Stephanie Eltz
(CEO)Trauma and orthopaedic surgeon.
Dr Suman Saha
(Medical Director)Trauma and orthopaedic surgeon, and NHS Clinical Entrepreneur Fellow.